oprah glp 1 Oprah's GLP-1 Special: The 12‑Month Stop, 20‑Lb Regain, and a Shift to Lifelong Medication Oprah Winfrey Weight Loss: Star

Martin's Press, 1997 Nuttall S, Martin U, Sinclair A, Kendall M

Ultra-processed food intake and obesity: what really matters for healthprocessing or nutrient content

The SURPASS-2 trial showing tirzepatide achieving significantly greater HbA1c reduction and weight loss than semaglutide in T2DM patients, and the SURMOUNT trials showing up to 22% average body weight reduction in obese patients, have established tirzepatide as the clinical performance leader in the class

10.1053/jhep.2000.9602

For functional factors supported by sufficient human evidence, stratified application can be made according to their primary effects

The TrumpRx tiers and emerging Medicare coverage aim to narrow that spread by introducing flat lower-cost options for participating formulations, reducing the unpredictability of retail markups